[Hypoprothrombinemia and bleeding associated to treatment with cholestyramine (author's transl)].
D000328:Adult; D002779:Cholestasis / Q000188:drug therapy; D002792:Cholestyramine Resin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced* / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D014812:Vitamin K / Q000627:therapeutic use
D002792:Cholestyramine Resin; D014812:Vitamin K
Hipoprotrombinemia y sindrome hemorragiparo asociado a tratamiento con colestiramina.